Skip to main content

Proposed Future Roundup Claims Settlement Opposed By Lawyers

Proposed Future Roundup Claims Settlement Opposed By Lawyers

Proposed Future Roundup Claims Settlement Opposed By Lawyers

Introduction

Last week, an amici curiae brief was filed by 93 law firms and 167 lawyers opposing the proposed settlement of future claims that would be brought against the widely used weedkiller Roundup.

The brief has now been joined by the National Trial Lawyers (NTL) President, individually and on behalf of the organization’s approximately 14,000 members. The NTL president who was also the past President of the American Association for Justice filed the Joinder in Opposition brief in federal court in San Francisco on Monday.

The organization agreed with the brief that the proposed settlement would endanger access to justice for millions of people in the proposed class and would prevent them from holding the company liable.

Bayer announced the proposed settlement in a press release, stating that the company has set aside $2 billion to resolve future legal claims. According to the plan, Monsanto’s parent company will be paying $2 billion over a period of four-years to cover outreach and diagnostic assistance of individuals who have been diagnosed with non-Hodgkin’s lymphoma and were exposed to Roundup prior to their diagnosis.

Recently, this week, an organizer for the activist group Migrant Justice stated that in the $2 billion settlement deal there is a major exclusionary factor that makes it difficult for migrant farmworkers in Vermont to receive any kind of compensation.

The settlement, if happened, will put a stay on the litigation for four years and would dissolve all class members’ claims for punitive damages and medical monitoring. Thereby a secret science panel would be formed to determine if members agree with all three juries to hear the evidence that the weedkiller causes cancer.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Supreme Court Upholds Flavored Vape Ban

Categories: E-Cigarette: JUUL

The U.S. Supreme Court has unanimously upheld a decision by the Food and Drug Administration (FDA) to block the sale and marketing of certain flavored e-cigarette products.

The ruling supports the FDA’s authority to regulate tobacco…

Judge Rejects JnJ's $10B Talc Lawsuit Settlement

Categories: Talcum

Johnson & Johnson's shares fell more than 5% after a U.S. bankruptcy judge rejected its $10 billion settlement proposal aimed at resolving over 60,000 lawsuits. 

These lawsuits allege that the company’s…

Tepezza Hearing Loss MDL: Bellwether Trials Set for 2026

Categories: Tepezza

A U.S. District Judge overseeing Tepezza hearing damage lawsuits nationwide has scheduled four bellwether trials for 2026. These trials are intended to help both parties assess how juries may respond to the evidence and testimonies that could be…

🛠️ You Have Unfinished Work. We’ll Finish It — Free Trial.            
Free Trial + 25% Off All DLs & Med Review Case Backlog!

Only 12 Firms Can Join – First Come, First Served